Status of antibiotic use in hospitalized children with community-acquired pneumonia in multiple regions of China
WEI Wei1, WANG Xue-Feng2, LIU Jian-Ping3, SHEN Kun-Ling4, MA Rong5, CUI Zhen-Ze6, DENG Li7, LI Yan-Ning8, JIANG Zhi-Yan9, XU Hua10, WANG Li-Ning11, FENG Xiao-Chun12, WU Zhen-Qi2, LIU Zhao-Lan3, HUANG Yan6, HE Chun-Hui7, LIU Hua10, ZHAO Xue2, WANG Zi2, HAO Ou-Mei2
First Clinical Medical Institute, Liaoning University of Traditional Chinese Medicine, Shenyang 110032, China
Abstract：Objective To investigate the use of antibiotics in children with community-acquired pneumonia (CAP) in multiple regions of China, and to provide a reference for CAP standard treatment and rational antibiotic use in children. Methods The medical data of 1383 children with CAP who were hospitalized in the department of pediatrics in 10 grade A tertiary hospitals from 9 cities between April 14, 2014 and January 1, 2016 were reviewed, to analyze the status of antibiotic use in hospitalized children in North China, Northeast China, East China, and South China. Results The overall rate of antibiotic use in children with CAP was 89.08%, with 88.7% in North China, 95.5% in Northeast China, 83.3% in East China, and 86.6% in South China. The main types of antibiotics used were cephalosporins, macrolides, compound preparations of β-lactam antibiotics, polyphosphoric broad-spectrum antibiotics and other β-lactam antibiotics. The selection of antibiotics was generally rational, but antibiotics were still used in some patients with viral infection alone or a combined use of ≥ 2 kinds of antibiotics were noted in some patients with infection caused by one kind of pathogen. Irrational antibiotic use was observed in 131 children (10.63%). Conclusions There are high rates of antibiotic use and irrational use of antibiotics among children with CAP. Standard management of antibiotic use in children with CAP should be strengthened.
WEI Wei,WANG Xue-Feng,LIU Jian-Ping et al. Status of antibiotic use in hospitalized children with community-acquired pneumonia in multiple regions of China[J]. CJCP, 2019, 21(1): 11-17.
Bradley JS, Byington CL, Shah SS, et al. The Management of community-acquired pneumonia in infants and children older than 3 months of age:clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America[J]. Clin Infect Dis, 2011, 53(7):e25-e76.
[9]
Harris M, Clark J, Coote N, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children:update 2011[J]. Thorax, 2011, 66 Suppl 2:ii1-23.
[10]
Zar HJ, Jeena P, Argent A, et al. Diagnosis and management of community-acquired pneumonia in childhood-South African Thoracic Society Guidelines[J]. S Afr Med J, 2005, 95(12 Pt 2):977-981, 984-990.
[11]
Kabra SK, Lodha R, Pandey RM. Antibiotics for communityacquired pneumonia in children[J]. Cochrane Database Syst Rev, 2010, (3):CD004874.
[12]
Song JH, Jung SI, Ko KS, et al. High prevalence of antimicrobial resistancec among clinical Streptococcus pneumonia isolates in asia (an ANSORP study)[J]. Antimicrob Agents Chemother, 2004, 48(6):2101-2107.
